Final-I-Am-Biotech-Logo-2-color1Jim Greenwood, President and CEO of the Biotechnology Industry Organization (BIO) is asking those in the biotech industry to support their work and connect you with others across the industry by joining the IAmBiotech community today.

Every day, the men and women in the biotech industry work to solve our most daunting challenges. From the fight against deadly diseases to feeding a growing world population to stopping global warming, you are there on the front lines.

To support your work and connect you with others across the industry, we launched a new website this past year: IAmBiotech.org.

Join the IAmBiotech community today, and you’ll be entered to win free roundtrip airfare and a complimentary registration to the 2010 BIO International Convention in Chicago.

To sign up and enter to win, visit:
http://IAmBiotech.org/join

As part of the biotech industry, you are at the forefront of the innovation economy.

In order to build a better future through biotechnology, we must come together online and offline to collaborate, network and tell our stories. That’s what IAmBiotech is all about.

By signing up, you’ll gain access to some great features including:

  • Insider insights on the direction of the industry from top CEOs and thought leaders;
  • Networking events in your area and the latest tips on how to make connections both online and offline;
  • News and alerts about the legislation and regulatory issues that could impact your business;
  • Social media resources, including advice on how LinkedIn, Twitter and Facebook can help your bottom line;
  • And opportunities to educate the public about how you’re helping to heal, fuel and feed the world.

Sign up today to be entered to win a free registration to the
2010 BIO International Convention:
http://IAmBiotech.org/join

We’re building this movement to support the critical work you do and to help you share that work with the world.

Please join us.
Jim Greenwood
President and CEO
Biotechnology Industry Organization (BIO)

Comments are closed.